Share

Dis-Chem exceeds R30bn revenue mark

Pharmaceutical retailer Dis-Chem saw improved earnings for the year until February. Backed by strong online sales and its acquisition strategy, group headline earnings per share were almost up by 30 per cent and revenue exceeded $30 billion.
Mon, 23 May 2022 16:09:28 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.